These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 18663343)

  • 1. Clinical experience with eperisone in the treatment of acute low back pain.
    Beltrame A; Grangiè S; Guerra L
    Minerva Med; 2008 Aug; 99(4):347-52. PubMed ID: 18663343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Open experience with a new myorelaxant agent for low back pain.
    Sartini S; Guerra L
    Adv Ther; 2008 Oct; 25(10):1010-8. PubMed ID: 18836866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of eperisone in patients with low back pain: a double blind randomized study.
    Cabitza P; Randelli P
    Eur Rev Med Pharmacol Sci; 2008; 12(4):229-35. PubMed ID: 18727454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of eperisone hydrochloride in the treatment of acute musculoskeletal spasm associated with low back pain: a randomized, double-blind, placebo-controlled trial.
    Chandanwale AS; Chopra A; Goregaonkar A; Medhi B; Shah V; Gaikwad S; Langade DG; Maroli S; Mehta SC; Naikwadi A; Pawar DR
    J Postgrad Med; 2011; 57(4):278-85. PubMed ID: 22120855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eperisone versus tizanidine for treatment of chronic low back pain.
    Rossi M; Ianigro G; Liberatoscioli G; Di Castelnuovo A; Grimani V; Garofano A; Camposarcone N; Nardi LF
    Minerva Med; 2012 Jun; 103(3):143-9. PubMed ID: 22653094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of eperisone in patients with spastic palsy: a cross-over, placebo-controlled dose-ranging trial.
    Bresolin N; Zucca C; Pecori A
    Eur Rev Med Pharmacol Sci; 2009; 13(5):365-70. PubMed ID: 19961042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of thiocolchicoside in Indian patients suffering from low back pain associated with muscle spasm.
    Soonawalla DF; Joshi N
    J Indian Med Assoc; 2008 May; 106(5):331-5. PubMed ID: 18839644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose cyclobenzaprine versus combination therapy with ibuprofen for acute neck or back pain with muscle spasm: a randomized trial.
    Childers MK; Borenstein D; Brown RL; Gershon S; Hale ME; Petri M; Wan GJ; Laudadio C; Harrison DD
    Curr Med Res Opin; 2005 Sep; 21(9):1485-93. PubMed ID: 16197668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of eperisone and baclofen in spastic palsy: a double-blind randomized trial.
    Bresolin N; Zucca C; Pecori A
    Adv Ther; 2009 May; 26(5):563-73. PubMed ID: 19458926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of efficacy and psychomotor performances of thiocolchicoside and tizanidine in patients with acute low back pain.
    Ketenci A; Ozcan E; Karamursel S
    Int J Clin Pract; 2005 Jul; 59(7):764-70. PubMed ID: 15963201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a centrally-acting muscle relaxant, eperisone hydrochloride, on muscle sympathetic nerve activity in humans.
    Iwase S; Mano T; Saito M; Ishida G
    Funct Neurol; 1992; 7(6):459-70. PubMed ID: 1338431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclobenzaprine and naproxen versus naproxen alone in the treatment of acute low back pain and muscle spasm.
    Borenstein DG; Lacks S; Wiesel SW
    Clin Ther; 1990; 12(2):125-31. PubMed ID: 2141299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do cerebral potentials to magnetic stimulation of paraspinal muscles reflect changes in palpable muscle spasm, low back pain, and activity scores?
    Zhu Y; Haldeman S; Hsieh CY; Wu P; Starr A
    J Manipulative Physiol Ther; 2000 Sep; 23(7):458-64. PubMed ID: 11004649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transdermal eperisone elicits more potent and longer-lasting muscle relaxation than oral eperisone.
    Yang SI; Park HY; Lee SH; Lee SJ; Han OY; Lim SC; Jang CG; Lee WS; Shin YH; Kim JJ; Lee SY
    Pharmacology; 2004 Jul; 71(3):150-6. PubMed ID: 15161997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low back ache treatment with botulinum neurotoxin type A. Local experience in Kuwait.
    Nagarajan V; Al-Shubaili A; Ayad YM; Alexander J; Al-Ramezi K
    Med Princ Pract; 2007; 16(3):181-6. PubMed ID: 17409751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of muscle relaxant on the paraspinal muscle blood flow: a randomized controlled trial in patients with chronic low back pain.
    Sakai Y; Matsuyama Y; Nakamura H; Katayama Y; Imagama S; Ito Z; Okamoto A; Ishiguro N
    Spine (Phila Pa 1976); 2008 Mar; 33(6):581-7. PubMed ID: 18344850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical efficacy and safety of eperisone for low back pain: A systematic literature review.
    Bavage S; Durg S; Ali Kareem S; Dhadde SB
    Pharmacol Rep; 2016 Oct; 68(5):903-12. PubMed ID: 27371896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Commonly used muscle relaxant therapies for acute low back pain: a review of carisoprodol, cyclobenzaprine hydrochloride, and metaxalone.
    Toth PP; Urtis J
    Clin Ther; 2004 Sep; 26(9):1355-67. PubMed ID: 15530999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of medication in low back pain.
    Mens JM
    Best Pract Res Clin Rheumatol; 2005 Aug; 19(4):609-21. PubMed ID: 15949779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical application of eperisone hydrochloride to neurogenic bladder].
    Murayama K; Katsumi T; Tajika E; Nakamura T
    Hinyokika Kiyo; 1984 Mar; 30(3):403-8. PubMed ID: 6464913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.